Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995;24(3):229-40.
doi: 10.1007/BF01052839.

Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats

Affiliations

Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats

S Sugimoto et al. J Neurooncol. 1995.

Abstract

The present study was designed to find the reliable parameter(s) for the detection of early neurotoxicity following intracarotid (IC) administration of cisplatin. IC administration was performed for 60 minutes in female Wistar rats derived into four groups according to the dose given (1 mg, 1.2 mg, and 1.5 mg of cisplatin, and normal saline in control rats). Blood-brain barrier (BBB) permeability and local cerebral blood flow (LCBF) were measured by a double-tracer autoradiography technique using 1-[14C]-alpha-aminoisobutyric acid (14C-AIB) and 4-[18F] fluoroantipyrine (18F-FAP), respectively. Blood chemistry and neuropathology were also examined. BBB permeability was increased only on the ipsilateral side. This increase was dose-dependent, preceded the brain necrosis, and was statistically significant in the hypothalamus (1.2 mg group), auditory cortex and caudoputamen (1.5 mg group). Renal dysfunction was often observed. The changes in the LCBF did not occur until brain necrosis was noticeable. These findings demonstrate that the increase in the BBB permeability provides a sensitive and reliable indication of an early toxicity to brain tissue following IC administration of cisplatin.

PubMed Disclaimer

References

    1. J Cereb Blood Flow Metab. 1984 Dec;4(4):555-63 - PubMed
    1. J Neurooncol. 1989 May;7(1):39-45 - PubMed
    1. Cancer Treat Rep. 1984 Mar;68(3):505-13 - PubMed
    1. Toxicol Appl Pharmacol. 1976 Dec;38(3):535-47 - PubMed
    1. Stroke. 1984 Sep-Oct;15(5):896-900 - PubMed

Publication types

LinkOut - more resources